Jorge Castillo
Affinity Clinical Research Services · Dana-Farber Cancer Institute · Universidad Peruana Cayetano Heredia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jorge Castillo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:07 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05875441 · Efficacy and Safety Study of Moxidectin in Adults With ScabiesMedicines Development for Global Health · completed · Scabies · principal investigator
- Ph2NCT05734495 · Pirtobrutinib and Venetoclax in Waldenström MacroglobulinemiaDana-Farber Cancer Institute · active not recruiting · Waldenstrom Macroglobulinemia · principal investigator
- Ph1NCT04115059 · Dasatinib In Waldenström MacroglobulinemiaJorge J. Castillo, MD · terminated · Waldenstrom Macroglobulinemia, DASATINIB · principal investigator
- Ph1NCT01664871 · Pharmacokinetics of Diammine Silver FluorideUniversidad Peruana Cayetano Heredia · completed · Fluoride and Silver Pharmacokinetics of DSF Applied Topically to Teeth of Adults. Erythema, Bleeding, White Changes, Ulceration and Pigmentation Were Assessed · study chair
- Ph2NCT01119794 · Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After RituximabBrown University · terminated · Lymphoma, Non-Hodgkins · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:07 UTC. The ranking covers the 200 most relevant of 149 PubMed records, and a shared surname and initials can bring in a namesake. All 149 on PubMed
- Ibrutinib in previously treated Waldenström's macroglobulinemia.N Engl J Med · 2015800 citationsRCR 23.1
- Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.N Engl J Med · 2015797 citationsRCR 34.2
- 559 citationsRCR 14.3
- 410 citationsRCR 17.3
- 363 citationsRCR 9.2
- 243 citationsRCR 6.5
- Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.Stroke · 2003239 citationsRCR 5.6
- Neuroanatomical distribution of five semantic components of verbs: evidence from fMRI.Brain Lang · 2008226 citationsRCR 7.2
- Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.Lancet Oncol · 2017202 citationsRCR 6.9
- 189 citationsRCR 6.6